Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
2
×
life sciences
national blog main
2
×
san francisco blog main
abbvie
allergan
alzheimer's disease
boston
boston blog main
boston top stories
clinical trials
crispr
cynthia collins
editas medicine
gene editing
genetic testing
invitae
leber congenital amaurosis type 10
michelle robertson
non-invasive prenatal tests
parkinson's disease
prenatal tests
rare diseases
san francisco
san francisco top stories
singular bio
startups
svb leerink. puneet souda
voyager therapeutics
What
genetic
2
×
abbvie
ability
acquire
alliance
array
babies
bio
biotech
business
cost
deal
editas
editing
exits
expand
experimental
gene
invitae
low
maker
medical
medicines
offers
pact
partnership
prenatal
pruning
reached
research
returning
rights
screen
singular
terminated
test
tests
treatment
wide
Language
unset
Current search:
genetic
×
" national blog main "
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
